about
Epigenetic Regulation of Oxidative Stress in Ischemic StrokeErythropoietin treatment in murine multiple myeloma: immune gain and bone loss.Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma.A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysisKinase inhibitors as potential agents in the treatment of multiple myeloma.Myeloid-derived suppressor cells in B cell malignancies.Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma.The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based studyBridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.Single cell functional analysis of multiple myeloma cell populations correlates with diffusion profiles in static microfluidic coculture systemsEffect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress.Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries.Histone deacetylase inhibitor NaBut suppresses cell proliferation and induces apoptosis by targeting p21 in multiple myeloma.Knockdown of REGγ inhibits the proliferation and migration and promotes the apoptosis of multiple myeloma cells by downregulating NF-κB signal pathway.3D-Dynamic Culture Models of Multiple Myeloma.cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance.Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma.Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma.Ibrutinib targets microRNA-21 in multiple myeloma cells by inhibiting NF-κB and STAT3.Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance.Daratumumab: Dawn of a New Paradigm in Multiple Myeloma?Effects of microRNA-20a on the proliferation, migration and apoptosis of multiple myeloma via the PTEN/PI3K/AKT signaling pathway.Identification of a novel c-Myc inhibitor with antitumor effects on multiple myeloma cellsLithium chloride inhibits cell survival, overcomes drug resistance, and triggers apoptosis in multiple myeloma via activation of the Wnt/β-catenin pathway
P2860
Q26743597-7D56C9DD-D3B5-40CC-BEF3-1692B68291C8Q37144501-C7248389-62C1-402D-A8BD-38100CDCF6B6Q37233276-C3510C50-A96B-43D5-92B9-D3B485F59243Q37375516-767217AD-5EF1-4E78-8480-5BCD18849F9AQ37697253-66A86EAA-0483-4ED4-A95F-67C0CFA0D52DQ38578686-0666D82E-DE9D-47A6-9A02-EDB728AAF906Q38637046-920C0B7B-D4A1-42CC-B74B-025EDED543E9Q38714291-FF18926D-D435-49BB-983C-1477279E38E1Q38896793-56CCDEB0-2F02-4B36-9281-AD841BA54669Q39539030-7B269E65-AED1-4575-A949-ECE4608AB7B0Q41396044-F4C61CEA-EFF3-4286-9D9B-ECFA065113C1Q41449149-E247EF9E-8B99-4ADD-AB59-1C1B09108D32Q42314593-B8B66E2C-BDF0-472B-AA82-2B32528445F4Q42776492-91E712E6-851B-4CD3-91CD-BBD5064D97B8Q45761043-3501029D-B106-4807-8E42-F7B43042F48CQ47175684-7EF3C091-1EA7-4084-8E99-E29F3053FF11Q47666357-FBBBC50F-E357-41EA-95E9-AF39F6652CDBQ47999671-082FC07D-4546-4ED1-8318-16B4E2936D90Q48507201-CC14ADDE-2A3A-4306-930B-14489FBA5306Q49166966-8D468556-837C-4D75-BE01-FAD014A0540FQ49569621-481C00B1-0A71-4026-965F-D9A9DB5B7284Q50102610-C1F6F446-ED59-4CE0-9B1E-20F2741710B0Q52859066-84D69F43-7EC8-4B04-9404-BFAFE86F5ABDQ55021985-5B6C2689-1E25-4C55-BD51-BC17C956C995Q55362922-F26619D1-D924-4696-84EE-7971936D0E9FQ58719353-671A8CA4-3CE7-4DD4-B7DC-C31A69D8D3E7Q58776006-C90F3E22-028A-4213-B62E-49BF5D294CA2
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Novel therapeutic strategies for multiple myeloma
@ast
Novel therapeutic strategies for multiple myeloma
@en
Novel therapeutic strategies for multiple myeloma
@nl
type
label
Novel therapeutic strategies for multiple myeloma
@ast
Novel therapeutic strategies for multiple myeloma
@en
Novel therapeutic strategies for multiple myeloma
@nl
prefLabel
Novel therapeutic strategies for multiple myeloma
@ast
Novel therapeutic strategies for multiple myeloma
@en
Novel therapeutic strategies for multiple myeloma
@nl
P2860
P3181
P1476
Novel therapeutic strategies for multiple myeloma
@en
P2093
Naoya Mimura
Teru Hideshima
P2860
P304
P3181
P356
10.1016/J.EXPHEM.2015.04.010
P407
P577
2015-08-01T00:00:00Z